Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression
Molecular profiling and the discovery of drugs that target specific activating mutations have allowed the personalization of treatment for non-small cell lung cancer (NSCLC). The epithelial growth factor receptor (EGFR) is frequently over-expressed and/or aberrantly activated in different cancers, i...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | anglais |
| Publié: |
2016
|
| Accès en ligne: | https://doi.org/10.1634/theoncologist.2016-0285 https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0285 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|